Details checkedClinical trial listing onlyCheckedregistry

Fudan intracochlear glucocorticoid SSNHL study

Also known as: Intracochlear Glucocorticoid SSNHL Study, Intracochlear Injection of Glucocorticoid, intracochlear triamcinolone acetonide injection, intracochlear dexamethasone injection, NCT07134075

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Steroid/Anti-inflammatory

Stage

Phase 2

Status

Active

Target Gene

—

Route / Mode

Intracochlear or intratympanic steroid injection

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

China

Population

adult, sudden, sensorineural, steroid, salvage-treatment

Trial IDs

Mechanism

Intracochlear triamcinolone or dexamethasone through the round-window membrane, compared with intratympanic dexamethasone approaches, as salvage treatment for total sudden sensorineural hearing loss.

Indications

Hearing Loss Sudden Hearing Loss Sensorineural Hearing Loss Tinnitus

Notes

Verified as an Eye & ENT Hospital of Fudan University-led Phase 2 study of intracochlear glucocorticoid delivery for total SSNHL. The registry status is not yet recruiting, so it should not be presented as an active commercial product.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT07134075, intracochlear glucocorticoid

Open

Key Events

2025-08-21

Fudan intracochlear glucocorticoid SSNHL study first posted

Clinical Trials (1)

NCT07134075

Data Checks